TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor

Published:2020-01-22 Issue: Volume:7 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Wang Lili,Chang Xixi,Feng Jinli,Yu Jiyun,Chen Guozhu

Funder

National Natural Science Foundation of China-Yunnan Joint Fund

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference57 articles.

1. RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development.;Anderton;Cell Death Differ.,2019

2. Regulated cell death: signaling and mechanisms.;Ashkenazi;Annu. Rev. Cell Dev. Biol.,2014

3. RHIM-based protein:protein interactions in microbial defence against programmed cell death by necroptosis.;Baker;Semin. Cell Dev. Biol.,2018

4. TRADD mediates the tumor necrosis factor-induced apoptosis of L929 cells in the absence of RIP3.;Chang;Sci. Rep.,2017

5. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death.;Chen;Cell Res.,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dingxian pill alleviates hippocampal neuronal apoptosis in epileptic mice through TNF-α/TNFR1 signaling pathway inhibition;Journal of Ethnopharmacology;2024-11

2. Plant‐Derived Phytochemicals and Their Nanoformulations for Inducing Programed Cell Death in Cancer;Advanced Therapeutics;2024-08-20

3. A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death;Immunity;2024-07

4. The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation;Immunity;2024-07

5. Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors;Cell Death Discovery;2024-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3